BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 11712794)

  • 21. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy and prognosis of small breast cancers. Comparison of subcutaneous mastectomy procedures with ablatio mammae].
    Kieback DG; Beller FK; Nitsch CD; Krieg V; Nienhaus H; Niedner WE
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):754-70. PubMed ID: 2286314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of occult nodal metastasis in early breast carcinoma.
    Park D; Kåresen R; Naume B; Synnestvedt M; Beraki E; Sauer T
    Breast Cancer Res Treat; 2009 Nov; 118(1):57-66. PubMed ID: 19219629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
    Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
    Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
    Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
    J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
    Zhang B; Cao WF; Zhao HM; Song YQ; Ning LS; Niu Y; Hao XS; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):790-4. PubMed ID: 20021837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?!
    Gruber G; Menzi S; Forster A; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2005 Sep; 181(9):574-9. PubMed ID: 16170484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cox proportion hazard model multivariate analysis of prognosis of 1,484 axillary node-negative breast cancer patients].
    Shen K; Shen Z; Han Q
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):221-4. PubMed ID: 10920903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
    Yeh S; Tan LR; O'Connell TX
    Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmastectomy electron-beam-rotation irradiation in locally advanced breast cancer prognostic factors of locoregional tumor control.
    Hehr T; Budach W; Durst I; Glocker S; Classen J; Weinmann M; Christ G; Bamberg M
    Strahlenther Onkol; 2002 Nov; 178(11):624-32. PubMed ID: 12426673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.